Literature DB >> 20838861

Brain proton magnetic spectroscopy in long-term treatment of Wilson's disease patients.

Beata Tarnacka1, Wojciech Szeszkowski, Marek Gołębiowski, Anna Członkowska.   

Abstract

We reported the brain proton magnetic resonance spectroscopy (MRS) findings in 27 Wilson's disease (WD) patients treated more than 6 years in neurological (nWD) and hepatic (hWD) subgroups. We investigated four hWD patients, with no improvement and eight with marked improvement; and eight nWD patients with marked improvement and seven with no improvement of clinical status. In nWD patients with improvement the MRS showed significantly higher Cho/Cr, Glx/Cr ratios levels. In hWD patients with no improvement the lower Cho/Cr and in nWD significantly lower NAA/Cr and higher Cho/Cr and Lip/Cr ratios were detected. In nWD patients with improvement the spectroscopic pattern, can be related to gliosis. In patients with no neurological improvement a persistent neuronal dysfunction can occur, perhaps as a result of copper or iron deposition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20838861     DOI: 10.1007/s11011-010-9214-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  16 in total

Review 1.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  Wilson's disease: cranial MRI observations and clinical correlation.

Authors:  S Sinha; A B Taly; S Ravishankar; L K Prashanth; K S Venugopal; G R Arunodaya; M K Vasudev; H S Swamy
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

Review 3.  Proton MRS in neurological disorders.

Authors:  S Bonavita; F Di Salle; G Tedeschi
Journal:  Eur J Radiol       Date:  1999-05       Impact factor: 3.528

4.  Proton MR spectroscopy in Wilson disease: analysis of 36 cases.

Authors:  Leandro T Lucato; Maria Concepción G Otaduy; Egberto R Barbosa; Alexandre A C Machado; Alexander McKinney; Luiz A Bacheschi; Milberto Scaff; Giovanni G Cerri; Claudia C Leite
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

5.  Initial and follow-up brain MRI findings and correlation with the clinical course in Wilson's disease.

Authors:  J K Roh; T G Lee; B A Wie; S B Lee; S H Park; K H Chang
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

6.  Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.

Authors:  S D Taylor-Robinson; J Sargentoni; C D Marcus; M Y Morgan; D J Bryant
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

7.  Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.

Authors:  R Kreis; B D Ross; N A Farrow; Z Ackerman
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

8.  MR spectroscopy in monitoring the treatment of Wilson's disease patients.

Authors:  Beata Tarnacka; Wojciech Szeszkowski; Marek Golebiowski; Anna Czlonkowska
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

9.  Neuropathological findings in penicillamine-treated patients with Wilson's disease.

Authors:  D S Horoupian; I Sternlieb; I H Scheinberg
Journal:  Clin Neuropathol       Date:  1988 Mar-Apr       Impact factor: 1.368

10.  Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease.

Authors:  R A Page; C A Davie; D MacManus; K A Miszkiel; J M Walshe; D H Miller; A J Lees; A H V Schapira
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

View more
  2 in total

Review 1.  Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015).

Authors:  Giulio Zuccoli; Michael Paul Yannes; Raffaele Nardone; Ariel Bailey; Amy Goldstein
Journal:  Neuroradiology       Date:  2015-07-31       Impact factor: 2.804

2.  The Impact of Acetyl-CoA and Aspartate Shortages on the N-Acetylaspartate Level in Different Models of Cholinergic Neurons.

Authors:  Marlena Zyśk; Monika Sakowicz-Burkiewicz; Piotr Pikul; Robert Kowalski; Anna Michno; Tadeusz Pawełczyk
Journal:  Antioxidants (Basel)       Date:  2020-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.